Targeting quiescent E. coli for prevention of recurrent urinary tract infections
Targeting quiescent E. coli for prevention of recurrent urinary tract infections
批准号:
10394445
负责人:
Bongsup P Cho
金额:
$26.88万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-30 至 2024-04-30
关键词:
AffectAntibiotic ResistanceAntibiotic TherapyAntibiotic susceptibilityAntibioticsAreaBacteriaBasic ScienceBiological ModelsBiomedical ResearchBladderBloodCell CycleCell DensityCell ProliferationCellsClinicalCollaborationsCuesDetectionDiagnosisEnvironmentEnvironmental HealthEpithelial CellsEscherichia coliFacultyFluorescence MicroscopyFundingFutureGenesGlucoseGoalsGrowthHealthIn VitroInfectionInstitutionInvestigationLabelLaboratoriesLeadLibrariesMetabolicModelingMolecularMonitorMulti-Drug ResistanceOintmentsOrganismParentsPathogenesisPatientsPeer ReviewPeptidesPeptidoglycanPhylogenetic AnalysisPopulation DensityPositioning AttributePreventionPrincipal InvestigatorProliferatingPublicationsPyelonephritisRecurrenceReportingResearchResearch ActivityResearch PersonnelResuscitationRhode IslandSignal TransductionStaphylococcus aureusTestingTherapeutic InterventionTimeTraining ProgramsUnited StatesUniversitiesUrinary tract infectionUrineUropathogenic E. coliUrothelial CellWomanWomen&aposs HealthWorkantibiotic tolerancebeta-Lactamscommunity collegedensityexperienceexperimental studyfallsimprovedin vitro Modelinterspecies communicationlead candidatemutantpandemic diseasepathogenic bacteriapharmacophorepreventprogramsrecurrent infectionresistance generesistant strainresponsescreeningstemstudent trainingtherapeutic developmenttreatment strategyundergraduate studentuniversity student
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Program Director/Principal Investigator (Last, First, Middle): Cho, Bongsup P.
PROJECT SUMMARY
In the United States, there are approximately 11 million urinary tract infections (UTIs) reported each year
and more than 50% of women will be diagnosed with at least one UTI. Twenty-seven percent of patients
with a UTI experience a recurrence within 12 months, even after successful antibiotic treatment.
Uropathogenic Escherichia coli (UPEC), a leading cause of initial and recurring UTIs, are thought to
survive antibiotic treatment by entering a quiescent state in bladder epithelial cells, which allows them
to resume growth at a later time once antibiotic treatment is halted. In this research plan, we will conduct
basic research to help better understand and treat recurrent urinary tract infections, which significantly
impact women’s health. We propose to synthesize, identify and characterize molecules that reverse
UPEC quiescence in an in vitro model system to inform on possible lead candidates for the development
of therapeutic agents to treat recurrent UTIs. To date, we have identified several molecules that function
as cues to induce proliferation of quiescent UPEC, enabling the bacterial cells to regain antibiotic-
sensitivity.
The overarching goal of the Rhode Island IDeA Network of Biomedical Research (RI-INBRE) program
is to improve institutional research capacity for biomedical excellence and hands-on student training in
RI. The work proposed with this supplement will be carried out at a primarily undergraduate institution
(PUI) in RI, Salve Regina University (Dr. Susan Meschwitz), in collaboration with University of Rhode
Island investigators (Dr. Jodi Camberg and Dr. David Rowley). Prior RI-INBRE funding to the Meschwitz
laboratory has provided research opportunities for 15 undergraduate students, many of whom have co-
authored peer-reviewed publications and pursued advanced degrees. This supplemental project falls
within the broad scientific thematic area of Environmental Health Sciences by proposing to develop and
synthesize small peptides that function as environmental cues to alter the course of uropathogenic
infections. This research is aligned with the stated aims of the parent RI-INBRE program, including: (1)
improve PUI faculty in developing productive and sustainable hands-on student training programs; (2)
promote strong collaboration between PUI and URI faculty investigators; and (3) increase participation
of PUI and community college students in research activities at URI.
PHS 398 (Rev. 03/2020 Approved Through 02/28/2023) OMB No. 0925-0001
Page 5
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Arylamine DNA adduct recognition in eukaryotic nucleotide excision repair
-
批准号:9372223
-
项目类别:
-
资助金额:$20.92万
-
财政年份:2017
-
负责人:Bongsup P Cho
-
依托单位:
Acquisition of Biacore T-100 at URI
-
批准号:8052075
-
项目类别:
-
资助金额:$35.17万
-
财政年份:2011
-
负责人:Bongsup P Cho
-
依托单位:
BRIN: URI: TMSR/CHEMICAL CARCINOGENESIS SUBCORE
-
批准号:6973513
-
项目类别:
-
资助金额:$2.68万
-
财政年份:2004
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:7626171
-
项目类别:
-
资助金额:$30.01万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:8022957
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:8444271
-
项目类别:
-
资助金额:$27.14万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of AF-modified DNA Structures
-
批准号:7106353
-
项目类别:
-
资助金额:$27.12万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of AF-modified DNA Structures
-
批准号:6767556
-
项目类别:
-
资助金额:$27.84万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:7798216
-
项目类别:
-
资助金额:$30.98万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of AF-modified DNA Structures
-
批准号:6921364
-
项目类别:
-
资助金额:$27.81万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:8228104
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of AF-modified DNA Structures
-
批准号:6678377
-
项目类别:
-
资助金额:$28.43万
-
财政年份:2003
-
负责人:Bongsup P Cho
-
依托单位:
Sequence Effects of Arylamine-DNA Adducts: Repair and Replication
-
批准号:7622808
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2002
-
负责人:Bongsup P Cho
-
依托单位:
RI-INBRE CELs Equipment Request
-
批准号:10399192
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Rhode Island IDeA Network of Biomedical Research Excellence
-
批准号:9981272
-
项目类别:
-
资助金额:$15.27万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Rhode Island IDeA Network of Biomedical Research Excellence
-
批准号:10619572
-
项目类别:
-
资助金额:$53.21万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Rhode Island IDeA Network of Biomedical Research Excellence Equipment Purchase
-
批准号:10630423
-
项目类别:
-
资助金额:$21.44万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Nanoparticle-mediated drug delivery for inflammatory Arthritis
-
批准号:10399300
-
项目类别:
-
资助金额:$17.44万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Rhode Island IDeA Network of Biomedical Research Excellence
-
批准号:10192735
-
项目类别:
-
资助金额:$384.63万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
Cloud-Based Learning Module for Biomarker Discovery
-
批准号:10557620
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2001
-
负责人:Bongsup P Cho
-
依托单位:
海外基金